Quality metrics for resection: Are they reasonable?
|
|
- Berenice Charles
- 5 years ago
- Views:
Transcription
1 Quality metrics for resection: Are they reasonable? G. Alexander Patterson, MD Joseph C. Bancroft Professor of Surgery Division of Cardiothoracic Surgery Editor, Annals of Thoracic Surgery
2 History of Outcomes Research & Public Reporting The trustees of hospitals should see to it that an effort is made to follow up each patient they treat, long enough to determine whether the treatment given has permanently relieved the condition or symptoms complained of. Dr. Ernest Amory Codman, 1918
3 TO ERR IS HUMAN: BUILDING A SAFER HEALTH SYSTEM Institute of Medicine National Academy Press Public Reporting Pay for Performance Safety - Quality
4 Quality - Alphabet Soup
5 Standardization 36 International General Thoracic Surgeons Evidence Based
6 Global Outcomes for Lung Cancer International Consortium for Health Outcome Measurement Multi-disciplinary working group International consensus outcomes Case mix variables Survival, complications, patient reported domains (pain, fatigue, cough, dyspnea) Mak KS et al. Eur Resp J. 2016
7 Variance in Management of Stage IIIA (N2) Trans-Atlantic perspective that surgery should play a role in selected IIIA patients North America More likely to stage the mediastinum pre-op Less likely to offer surgery when N2 is identified pre-op More likely to use induction Rx Europe More likely to perform a more extensive lymph node dissection Rocco G et al. Annals Thor Surg 2016; 101:
8 Voluntary STS - GTSDB Provides participants with risk-adjusted semiannual performance reports that allow comparison of institutional outcomes against national benchmarks 1000 surgeons contributing data from over 300 centers 500,000 patients
9 GTSDB 2016 Updated risk models for lung resection and esophagectomy for cancer were reported Composite quality measures for lobectomy and esophagectomy were developed
10 GTSDB 2017 Upgrading the STS GTSD Establishing public reporting of lobectomy for lung cancer composite scores Creating an on-line dashboard Strengthening international collaboration with the European Society of Thoracic Surgery Registry
11 Performance measures ACSD..CABG, AVR, AVR+CABG GTSDB 2016 Lobectomy for lung cancer 20,657 patients were examined who underwent lobectomy at 231 institutions between 2011 and outcomes Risk-adjusted mortality Risk-adjusted major complications (any or none)
12 Ann Thorac Surg 2016;101: by The Society of Thoracic Surgeons
13 STS Composite Score for Rating Program Performance for Lobectomy Risk-adjusted mortality and major complication rates varied 3-fold from highest performing (3 star) to lowest performing (1 star) programs. 3 star (7%), 2 star (88%), 1 star (5%) 25% had insufficient volume (n=30: ) to permit star rating Kozower BD et al. Annals Thor Surg 2016; 101:
14 STS Updated Risk Models Logistic regression; 3 risk models for adverse events following resection Operative mortality, major morbidity, composite mortality and major morbidity 27,844 resections, 231 centers Fernandez FG et al. Ann Thor Surg 2016; 102:370-7.
15 STS Updated Risk Models Mortality 1.4%; morbidity 9.1% Predictors of mortality; age, male, FEV 1, BMI, cerebrovascular disease, steroids, CAD, PVD, renal dysfunction, Zubrod score, ASA rating, thoracotomy, induction Rx, reoperation, tumor stage, extent of resection (p<0.05 for all) Fernandez FG et al. Ann Thor Surg 2016; 102:370-7.
16 STS National Database Weaknesses Voluntary Expensive, $$ and personnel Multiple data fields 30 day follow-up
17 Longitudinal Follow-up in Older Patients Link STS database to Centers for Medicare and Medicaid Services (CMS) Medicare/Medicaid patient over age 65 26,055 patients Median survival for pathologic Stage yrs; Stage II-3.5 yrs; Stage III-2.4 yrs; Stage IV-2.2 yrs. Fernandez, FG et al. Annals Thor Surg 2016; 101: 2067
18 Failure to Rescue Important concept and possible measure of quality Variation in hospital mortality seems to be more strongly related to rescuing patients from complications than to the occurrence of complications. Farjah F et al. JTCVS 2015; 149: Kozower BD et al. JTCVS 2015; 149:
19 Ann Thorac Surg 2009;88: ATS 2009;88:1393
20 Quality Metrics NQF Endorsed Measures STS measures for GTS (lung cancer) Participation in a systematic national database Preoperative recording of clinical stage Preoperative recording of performance status Risk-adjusted morbidity Length of stay >14 days following lobectomy Risk adjusted morbidity and mortality for resection Seder CW et al. Annals Thor Surg 2016; 101:
STS General Thoracic Surgery Database (GTSD) Update
STS General Thoracic Surgery Database (GTSD) Update Benjamin D. Kozower, MD, MPH Professor of Surgery Chair, STS GTSD Co-Director, Surgical Outcomes Research Center Washington University St. Louis, MO
More informationThe STS Database is the Best Measure of Quality: CON
The STS Database is the Best Measure of Quality: CON Inderpal (Netu) S. Sarkaria, MD, FACS Vice Chairman, Clinical Affairs Director, Robotic Thoracic Surgery Co-Director, Esophageal and Lung Surgery Institute
More informationTreatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard
Treatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard AATS General Thoracic Surgery Symposium May 5, 2010 Thomas A. D Amico MD Professor of Surgery, Duke University Medical
More informationT3 NSCLC: Chest Wall, Diaphragm, Mediastinum
for T3 NSCLC: Chest Wall, Diaphragm, Mediastinum AATS Postgraduate Course April 29, 2012 Thomas A. D Amico MD Professor of Surgery, Chief of Thoracic Surgery Duke University Health System Disclosure No
More informationThe effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries. Dr. Christian Finley MD MPH FRCSC McMaster University
The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries Dr. Christian Finley MD MPH FRCSC McMaster University Disclosures I have no conflict of interest disclosures
More informationORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery
Nagoya J. Med. Sci. 79. 37 ~ 42, 2017 doi:10.18999/nagjms.79.1.37 ORIGINAL PAPER Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Naoki Ozeki, Koji
More informationComplex Thoracoscopic Resections for Locally Advanced Lung Cancer
Complex Thoracoscopic Resections for Locally Advanced Lung Cancer Duke Thoracoscopic Lobectomy Workshop March 21, 2018 Thomas A. D Amico MD Gary Hock Professor of Surgery Section Chief, Thoracic Surgery,
More informationThoracoscopic Lobectomy for Locally Advanced Lung Cancer. Masters of Minimally Invasive Thoracic Surgery Orlando September 19, 2014
for Locally Advanced Lung Cancer Masters of Minimally Invasive Thoracic Surgery Orlando September 19, 2014 Thomas A. D Amico MD Gary Hock Endowed Professor and Vice Chair of Surgery Chief Thoracic Surgery
More informationLung Cancer Resection on Cardiopulmonary Bypass. Daniel J. Boffa, MD Yale University
Lung Cancer Resection on Cardiopulmonary Bypass Daniel J. Boffa, MD Yale University None related to talk Disclosures Disclaimers I love operating on CPB Disclaimers I love operating on CPB I avoid it for
More informationPredicting Short Term Morbidity following Revision Hip and Knee Arthroplasty
Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty A Review of ACS-NSQIP 2006-2012 Arjun Sebastian, M.D., Stephanie Polites, M.D., Kristine Thomsen, B.S., Elizabeth Habermann,
More informationPneumonectomy After Induction Rx: Is it Safe?
Pneumonectomy After Induction Rx: Is it Safe? David J. Sugarbaker, M.D. Director, Chief, Division of Thoracic Surgery The Olga Keith Weiss Chair of Surgery of Medicine at, Pneumonectomy after induction
More informationSTS National Database
STS National Database The U.S. Agency for Healthcare Research and Quality (AHRQ) Learning Network for Chartered Value Exchanges (CVEs) Webinar: Using Registries for Health Care Quality Measurement Thursday,
More informationClinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD
Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD Gordon F. Murray Professor and Chairman Department of Cardiovascular & Thoracic Surgery WVU Heart and Vascular Institute
More informationVATS after induction therapy: Effective and Beneficial Tips on Strategy
VATS after induction therapy: Effective and Beneficial Tips on Strategy AATS Focus on Thoracic Surgery Mastering Surgical Innovation Las Vegas Nevada Oct. 27-28 2017 Scott J. Swanson, M.D. Professor of
More informationPreoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?
Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, Alan M. Speir MD, Mohammed
More informationFEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,
More informationSurgical Approaches to Pulmonary Metastases
Surgical Approaches to Pulmonary Metastases Raja M Flores MD Professor and Chief Thoracic Surgery Mount Sinai School of Medicine New York, New York History of Lung Metastasectomy 1882 Weinlechner +CW 1926
More informationMINIMALLY INVASIVE ESOPHAGECTOMY FOR CANCER: where do we stand?
MINIMALLY INVASIVE ESOPHAGECTOMY FOR CANCER: where do we stand? Ph Nafteux, MD Copenhagen, Nov 3rd 2011 Department of Thoracic Surgery, University Hospitals Leuven, Belgium W. Coosemans, H. Decaluwé, Ph.
More informationDisclosures. Preoperative Treatment: Chemotherapy or ChemoRT? Adjuvant chemotherapy helps. so what about chemo first?
Disclosures Preoperative Treatment: Chemotherapy or ChemoRT? Advisory boards Genentech (travel only), Pfizer Salary support for clinical trials Celgene, Merck, Merrimack Matthew Gubens, MD, MS Assistant
More informationThe Society of Thoracic Surgeons General Thoracic Surgery Database: Establishing Generalizability to National Lung Cancer Resection Outcomes
The Society of Thoracic Surgeons General Thoracic Surgery Database: Establishing Generalizability to National Lung Cancer Resection Outcomes Damien J. LaPar, MD, MS, Castigliano M. Bhamidipati, DO, MS,
More informationPrapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital
Prapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital Only 20-30% of patients with lung cancer are potential candidates for lung resection Poor lung function alone ruled
More informationImpact of Tidal Volume on Complications after Thoracic Surgery
Management of One-lung Ventilation Impact of Tidal Volume on Complications after Thoracic Surgery ABSTRACT Background: The use of lung-protective ventilation (LPV) strategies may minimize iatrogenic lung
More informationTools, Reports, and Resources
Tools, Reports, and Resources What the National Cancer Database (NCDB) does for CoC-Accredited Programs By using the NCDB, CoC-accredited programs can proactively improve delivery and quality of care for
More informationSagar Damle, MD University of Colorado Denver May 23, 2011
Sagar Damle, MD University of Colorado Denver May 23, 2011 We have debated many times. Here are the topics, and a recap of the last few Pre-operative nutrition Babu pro; Damle con Utility of ECMO Babu
More informationTHE NATIONAL QUALITY FORUM
THE NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Patient Outcomes Table of Measures Submitted-Phase 1 As of March 5, 2010 Note: This information is for personal and noncommercial use
More informationThe Pennsylvania State University. The Graduate School. Department of Public Health Sciences
The Pennsylvania State University The Graduate School Department of Public Health Sciences THE LENGTH OF STAY AND READMISSIONS IN MASTECTOMY PATIENTS A Thesis in Public Health Sciences by Susie Sun 2015
More informationThe Itracacies of Staging Patients with Suspected Lung Cancer
The Itracacies of Staging Patients with Suspected Lung Cancer Gerard A. Silvestri, MD,MS, FCCP Professor of Medicine Medical University of South Carolina Charleston, SC silvestri@musc.edu Staging Lung
More informationAshleigh Clark 1, Jessica Ozdirik 2, Christopher Cao 1,2. Introduction
Review Article Page 1 of 5 Thoracotomy, video-assisted thoracoscopic surgery and robotic video-assisted thoracoscopic surgery: does literature provide an argument for any approach? Ashleigh Clark 1, Jessica
More informationJ Clin Oncol by American Society of Clinical Oncology INTRODUCTION
JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Minimally Invasive Lung Cancer Surgery Performed by Thoracic Surgeons as Effective as Thoracotomy Daniel J. Boffa, Andrzej S. Kosinski, Anthony
More informationThe right middle lobe is the smallest lobe in the lung, and
ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,
More informationSurgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents
Table of Contents #0113: Participation in a Systematic Database for Cardiac Surgery... 2 #0114: Post-operative Renal Failure... 2 #0115: Surgical Re-exploration... 3 #0116: Anti-Platelet Medication at
More informationMeasure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care
Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationBelow is summarised some of the tools and papers that are worth looking at if you have an interest in the area.
What happens to the high risk patients who don t die? Perioperative SIG meeting PBLD Noosa 2015 Nicola Broadbent, Auckland, NZ In the process of writing this problem based learning discussion I have read
More informationMitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia
Mitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia Disclosures Edwards Lifesciences Consultant Abbott Mitraclip Royalties
More informationChairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine
Leonard N. Girardi, M.D. Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine New York, New York Houston Aortic Symposium Houston, Texas February 23, 2017 weill.cornell.edu
More informationLung Cancer in Octogenarians: Factors Affecting Morbidity and Mortality After Pulmonary Resection
ORIGINAL ARTICLES: SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS
More informationRobotic lobectomy has the greatest benefit in patients with marginal pulmonary function
Kneuertz et al. Journal of Cardiothoracic Surgery (2018) 13:56 https://doi.org/10.1186/s13019-018-0748-z RESEARCH ARTICLE Open Access Robotic lobectomy has the greatest benefit in patients with marginal
More informationMeasure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care
Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:
More informationModeling major lung resection outcomes using classification trees and multiple imputation techniques
European Journal of Cardio-thoracic Surgery 34 (2008) 1085 1089 www.elsevier.com/locate/ejcts Modeling major lung resection outcomes using classification trees and multiple imputation techniques Mark K.
More informationROBOT SURGEY AND MINIMALLY INVASIVE TREATMENT FOR LUNG CANCER
ROBOT SURGEY AND MINIMALLY INVASIVE TREATMENT FOR LUNG CANCER Giulia Veronesi European Institute of Oncology Milan Lucerne, Samo 24 th - 25 th January, 2014 DIAGNOSTIC REVOLUTION FOR LUNG CANCER - Imaging
More informationMinimally Invasive Esophagectomy
Minimally Invasive Esophagectomy M A R K B E R R Y, M D A S S O C I AT E P R O F E S S O R D E PA R T M E N T OF C A R D I O T H O R A C I C S U R G E R Y S TA N F O R D U N I V E R S I T Y S E P T E M
More informationVariability in length of stay after uncomplicated pulmonary lobectomy: is length of stay a quality metric or a patient metric?
European Journal of Cardio-Thoracic Surgery 49 (2016) e65 e71 doi:10.1093/ejcts/ezv476 Advance Access publication 27 January 2016 ORIGINAL ARTICLE Cite this article as: Giambrone GP, Smith MC, Wu X, Gaber-Baylis
More informationWashington State Spine Surgery
Washington State Spine Surgery Spine SCOAP Statistics and Key Findings, 2015-2017 Arman Dagal, MD, FRCA Spine SCOAP Medical Director Ian Painter, PhD SCOAP Biostatistician Vickie Kolios-Morris, MSHSA,
More informationHistory of Surgery for Lung Cancer
Welcome to Master Class for Oncologists Session 1: 7:30 AM - 8:15 AM San Francisco, CA October 23, 2009 Innovations in The Surgical Treatment of Lung Cancer Speaker: Scott J. Swanson, MD 2 Presenter Disclosure
More informationNewly Diagnosed Cases Cancer Related Death NCI 2006 Data
Multi-Disciplinary Management of Esophageal Cancer: Surgical and Medical Steps Forward Alarming Thoracic Twin Towers 200000 150000 UCSF UCD Thoracic Oncology Conference November 21, 2009 100000 50000 0
More informationThe New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process
The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process Wednesday, April 29, 2009 at 11 AM Central M. Asa Carter, CTR Manager, Approvals and Standards
More informationReducing lung volume in emphysema Surgical Aspects
Reducing lung volume in emphysema Surgical Aspects Simon Jordan Consultant Thoracic Surgeon Royal Brompton Hospital Thirteenth Cambridge Chest Meeting April 2015 Surgical aspects of LVR Why we should NOT
More informationNSQIP-P for the comparative analysis of resource utilization and disease-specific outcomes:
NSQIP-P for the comparative analysis of resource utilization and disease-specific outcomes: Implications for Benchmarking and Collaborative Quality Improvement Shawn J. Rangel, MD, MSCE ACS NSQIP Conference
More informationprocedures for severe Aortic stenosis Treatment
Italian OBservational Study of Effectiveness of AVR TAVI procedures for severe Aortic stenosis Treatment Subgroup Analyses Corrado Tamburino SOCIETA' ITALIANA DI CHIRURGIA CARDIACA onlus ITACTA ITALIAN
More informationSTAGE I INOPERABLE NSCLC RADIOFREQUENCY ABLATION OR STEREOTACTIC BODY RADIOTHERAPY?
STAGE I INOPERABLE NSCLC RADIOFREQUENCY ABLATION OR STEREOTACTIC BODY RADIOTHERAPY? MICHAEL LANUTI, MD American Association of Thoracic Surgeons Minneapolis, MN 2013 STAGE I INOPERABLE NSCLC RADIOFREQUENCY
More informationJ. MAXWELL CHAMBERLAIN MEMORIAL PAPER FOR GENERAL THORACIC SURGERY
J. MAXWELL CHAMBERLAIN MEMORIAL PAPER FOR SURGERY STS Database Risk Models: Predictors of Mortality and Major Morbidity for Lung Cancer Resection Benjamin D. Kozower, MD, MPH, Shubin Sheng, PhD, Sean M.
More informationParenchymal air leak is a frequent complication after. Pleural Tent After Upper Lobectomy: A Randomized Study of Efficacy and Duration of Effect
Pleural After Upper Lobectomy: A Randomized Study of Efficacy and Duration of Effect Alessandro Brunelli, MD, Majed Al Refai, MD, Marco Monteverde, MD, Alessandro Borri, MD, Michele Salati, MD, Armando
More informationUtility of PET-CT for detection of N2 or N3 nodal mestastases in the mediastinum in patients with non-small cell lung cancer (NSCLC)
Utility of PET-CT for detection of N2 or N3 nodal mestastases in the mediastinum in patients with non-small cell lung cancer (NSCLC) Poster No.: C-1360 Congress: ECR 2015 Type: Scientific Exhibit Authors:
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationPost-Induction PET Does Not Correlate with Persistent Nodal Disease or Overall Survival in Surgically Treated Stage IIIA Non-Small Cell Lung Cancer
Post-Induction PET Does Not Correlate with Persistent Nodal Disease or Overall Survival in Surgically Treated Stage IIIA Non-Small Cell Lung Cancer R. Taylor Ripley, Kei Suzuki, Kay See Tan, Manjit Bains,
More informationTAAA / Spinal Cord Protection
TAAA / Spinal Cord Protection Hazim J. Safi, MD Professor and Chair Department of Cardiothoracic and Vascular Surgery McGovern Medical School The University of Texas Science Center at Houston Memorial
More informationIs Resection Superior to SBRT for Stage I Lesions. Traves Crabtree MD Professor of Surgery Southern Illinois University School of Medicine
Is Resection Superior to SBRT for Stage I Lesions Traves Crabtree MD Professor of Surgery Southern Illinois University School of Medicine I have nothing pertinent to disclose. Patterns of Recurrence for
More informationTristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease
Tristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease Jennifer E. Tseng, MD UFHealth Cancer Center-Orlando Health Sep 12, 2014 Background Approximately
More informationSOC s Guide to the 2013 CMS New Core Measures for Stroke
SOC s Guide to the 2013 CMS New Core Measures for Stroke Since 2004, the Centers for Medicare & Medicaid Services (CMS) has collected quality data from acute care hospitals on a voluntary basis under the
More informationVATS Metastasectomy. Inderpal (Netu) S. Sarkaria, MD, FACS
VATS Metastasectomy Inderpal (Netu) S. Sarkaria, MD, FACS Vice Chairman, Clinical Affairs Director, Robotic Thoracic Surgery Co-Director, Esophageal and Lung Surgery Institute Disclosures Speaking & Education:
More informationTAVI After PARTNER-2 : The Hamilton Approach
TAVI After PARTNER-2 : The Hamilton Approach James L. Velianou MD FRCPC Interventional Cardiology Hamilton General Hospital St Catharines General Hospital Associate Professor of Medicine McMaster University
More informationCancer Technical Report January 13, 2017
Cancer 2015-2017 Technical Report January 13, 2017 This report is funded by the Department of Health and Human Services under contract HHSM-500-2012-00009I Task Order HHSM-500-T0008 1 Contents Executive
More informationCurrent Issues in Thyroid Cancer Surgery in 2017
Current Issues in Thyroid Cancer Surgery in 2017 Dr. David Goldstein MD Msc FRCSC FACS Associate Professor, Department Otolaryngology Head & Neck Surgery, U of T Department of Surgical Oncology, Princess
More informationSurgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea
Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm
More informationMechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute
Mechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute Assistant Professor, Georgetown School of Medicine
More informationAtrial Fibrillation Ablation Thinktank
Atrial Fibrillation Ablation Thinktank Mitchell J. Magee, M.D. STS National Database Taskforce CRSTI Dallas, TX FDA, Silver Spring, MD April 27, 2009 STS National Database Current Status Update Adult Cardiac
More informationRecent evidence regarding resection rate, specialism and survival in lung cancer in the UK
Recent evidence regarding resection rate, specialism and survival in lung cancer in the UK Dr Mick Peake Glenfield Hospital, Leicester Clinical Lead, National Cancer Intelligence Network & National Lung
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #358: Patient-Centered Surgical Risk Assessment and Communication National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes 2018 OPTIONS FOR INDIVIDUAL MEASURES:
More informationExamination of Hospital-Level Variation in Preventing Post-Operative Sepsis
Examination of Hospital-Level Variation in Preventing Post-Operative Sepsis Elizabeth Berger, MD; Sanjay Mohanty MD MS; Lynn Zhou PhD; Mark Cohen, PhD; Bruce Hall MD PhD MBA; Cliff Ko, MD MS MSHS; Karl
More informationThe Society for Vascular Surgery Patient Safety Organization: Use of A Quality Registry for Practice Improvement
The Society for Vascular Surgery Patient Safety Organization: Use of A Quality Registry for Practice Improvement Georgia Vascular Society Adam W. Beck, MD, FACS September 9, 2017 Disclosures No relevant
More informationAccepted Manuscript. Current State of the Art for the Surgical Management of empyema thoracis. K. Robert Shen, M.D.
Accepted Manuscript Current State of the Art for the Surgical Management of empyema thoracis K. Robert Shen, M.D. PII: S0022-5223(18)32919-2 DOI: https://doi.org/10.1016/j.jtcvs.2018.11.006 Reference:
More informationSuperior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis
ORIGINAL ARTICLES: Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki, MD, and Hisao Asamura, MD
More informationIntraoperative Oncologic Staging and Outcomes for Lung Cancer Resection Vary by Surgeon Specialty
Intraoperative Oncologic Staging and Outcomes for Lung Cancer Resection Vary by Surgeon Specialty Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, and Paul H. Schipper, MD Department of Surgery,
More informationOn-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery
On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict
More informationImpact of Preoperative Bowel Preparation on the Risk of Clostridium Difficile after Colorectal Surgery: A Propensity Weighted Analysis
Impact of Preoperative Bowel Preparation on the Risk of Clostridium Difficile after Colorectal Surgery: A Propensity Weighted Analysis Ebram Salama, MD PGY-3 General Surgery Sir Mortimer B. Davis Jewish
More informationincluding prevention, healthy lifestyle behaviors, populations at risk & disparities (age, race/ ethnicity, gender, geographic & socioeconomic)
Endorsement Maintenance 2010 Identification of Gap Areas for which Evidence-based Surgery-related Measures are Needed Cardiac, General, Other Surgical Subspecialties The table below is a tool that identifies
More informationRobotic Surgery for Esophageal Cancer
Robotic Surgery for Esophageal Cancer Kemp H. Kernstine, MD PhD Division of Thoracic Surgery City of Hope Medical Center and Beckman Research Institute May 1, 2010 Esophageal Cancer on the Rise JNCI 2005,
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #51 (NQF 0091): Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
More informationWhat is an Adequate Lumpectomy Margin in 2018?
What is an Adequate Lumpectomy Margin in 2018? Stuart J. Schnitt, M.D. Brigham and Women s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School Boston, MA None Disclosures Topics Current
More information11/21/ M with LUL Mass Case Presentation / Round Table Discussion. Multiple-choice question What stage is this tumor?
MS 62M with LUL Mass Case Presentation / Round Table Discussion Dr. Jasleen Kukreja and Johannes Kratz Department of Thoracic Surgery University of California, San Francisco 62M, presented to clinic 6/2009
More informationSupplementary Online Content
Supplementary Online Content Won EJ, Lehman EB, Geletzke AK, et al. Association of postoperative hyperglycemia with outcomes among patients with complex ventral hernia repair. JAMA Surg. Published online
More informationThoracoscopic Lobectomy: Technical Aspects in Years of Progress
Thoracoscopic Lobectomy: Technical Aspects in 2015 16 Years of Progress 8 th Masters of Minimally Invasive Thoracic Surgery Orlando September 25, 2015 Thomas A. D Amico MD Gary Hock Professor of Surgery
More informationORIGINAL ARTICLE. Abstract INTRODUCTION
European Journal of Cardio-Thoracic Surgery 49 (2016) 1054 1058 doi:10.1093/ejcts/ezv378 Advance Access publication 24 November 2015 ORIGINAL ARTICLE Cite this article as: Begum SSS, Papagiannopoulos K,
More informationHani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz
Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for
More informationPostoperative Mortality in Lung Cancer Patients
Review Postoperative Mortality in Lung Cancer Patients Kanji Nagai, MD, Junji Yoshida, MD, and Mitsuyo Nishimura, MD Surgery for lung cancer frequently results in serious life-threatening complications,
More informationRed Blood Cell Conservation A Surgeon s Journey. Goya V. Raikar MD FACS, FCCP Oklahoma Heart Hospital
Red Blood Cell Conservation A Surgeon s Journey Goya V. Raikar MD FACS, FCCP Oklahoma Heart Hospital Red Blood Cell Conservation Clinical impetus Evidence based learning Program development Industry partnerships
More informationCancer Center Dashboard
Cancer Center Dashboard Measure Definition Benchmark Endorsed By Screening Breast Cancer Screening Percentage of eligible women 40-69 who received a mammogram within the past 24 months NCQA reported average:
More informationLeveraging Your Cancer Registry: A Strategy for Survey Success
CoC-trained consultants on staff Leveraging Your Cancer Registry: A Strategy for Survey Success Toni Hare, RHIT, CTR CoC-trained Consultant Vice President, CHAMPS Oncology November 27, 2012 Georgia s Best
More informationRegistry Highlights. Dale Daniel Symposium Hip Fracture Registry. Overall Volume by Year and Region 3/7/2014
Dale Daniel Symposium 2014 Registry Highlights Overview: Updated Volume NCAL/SCAL Snapshot Hip Fracture Registry Update Gary Zohman, MD SCAL Regional Lead Anaheim, CA Quarterly Quality Report Review Future
More informationWhat is the Role of Surgical Repair in 2012
What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th
More informationInduction chemotherapy followed by surgical resection
Surgical Resection for Residual N 2 Disease After Induction Chemotherapy Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Matthew A. Levin, BS, David E. Becker, MA, Roger Keresztes, MD, and Nasser
More informationStereotactic ablative radiotherapy in early NSCLC and metastases
Stereotactic ablative radiotherapy in early NSCLC and metastases Scheduled: 0810-0830 hrs, 10 March 2012 Professor Suresh Senan Department of Radiation Oncology SABR in stage I NSCLC A major treatment
More informationDe.3 If included in a composite, please identify the composite measure (title and NQF number if endorsed): n/a
NQF #1790 Risk-Adjusted Morbidity and Mortality for Lung Resection for Lung Cancer NATIONAL QUALITY FORUM Measure Submission and Evaluation Worksheet 5.0 This form contains the information submitted by
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adenocarcinoma, pancreatic ductal, laparoscopic distal pancreatectomy for, 61 Adrenal cortical carcinoma, laparoscopic adrenalectomy for, 114
More informationMaking the Most of Your Cancer Registry
www.champsods.com Making the Most of Your Cancer Registry Presenter: Toni Hare, Vice President CHAMPS Oncology Data Services Picture of girl here December 11, 2009 Learning Objectives Upon completion of
More informationLung Cancer Epidemiology. AJCC Staging 6 th edition
Surgery for stage IIIA NSCLC? Sometimes! Anne S. Tsao, M.D. Associate Professor Director, Mesothelioma Program Director, Thoracic Chemo-Radiation Program May 7, 2011 The University of Texas MD ANDERSON
More informationThoracic Surgery; An Overview
Thoracic Surgery What we see Thoracic Surgery; An Overview James P. Locher, Jr, MD Methodist Cardiovascular and Thoracic Surgery Lung cancer Mets Fungus and TB Lung abcess and empyema Pleural based disease
More informationTissue vs Mechanical What s the Data??
Biological (Tissue) Valve in a 60 year old patient: Debate Tissue vs Mechanical What s the Data?? Joseph E. Bavaria, MD Immediate-Past President - Society of Thoracic Surgeons (STS) Brooke Roberts-William
More informationBreast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015
Breast Surgery When Less is More and More is Less E MacIntosh, MD June 6, 2015 Presenter Disclosure Faculty: E. MacIntosh Relationships with commercial interests: None Mitigating Potential Bias Not applicable
More informationPercutaneous aortic valve replacement should NOT be preferred therapy for aortic stenosis
Percutaneous aortic valve replacement should NOT be preferred therapy for aortic stenosis James Bartholomew McClurken, MD FACC, FCCP, FACS, FESC Professor & Vice-Chair of Surgery, Temple University Hosp.,
More information